AVP
protein-codingarginine vasopressin, the group of Neuropeptides
Gene summary
This gene encodes a member of the vasopressin/oxytocin family and preproprotein that is proteolytically processed to generate multiple protein products. These products include the neuropeptide hormone arginine vasopressin, and two other peptides, neurophysin 2 and copeptin. Arginine vasopressin is a posterior pituitary hormone that is synthesized in the supraoptic nucleus and paraventricular nucleus of the hypothalamus. Along with its carrier protein, neurophysin 2, it is packaged into neurosecretory vesicles and transported axonally to the nerve endings in the neurohypophysis where it is either stored or secreted into the bloodstream. The precursor is thought to be activated while it is being transported along the axon to the posterior pituitary. Arginine vasopressin acts as a growth factor by enhancing pH regulation through acid-base transport systems. It has a direct antidiuretic action on the kidney, and also causes vasoconstriction of the peripheral vessels. This hormone can contract smooth muscle during parturition and lactation. It is also involved in cognition, tolerance, adaptation and complex sexual and maternal behaviour, as well as in the regulation of water excretion and cardiovascular functions. Mutations in this gene cause autosomal dominant neurohypophyseal diabetes insipidus (ADNDI). This gene is present in a gene cluster with the related gene oxytocin on chromosome 20. [provided by RefSeq, Nov 2015]
- ARVP
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~2.2 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AD
Disease ID:MONDO:0007450
Submitter: PanelApp Australia
Inheritance Pattern: AD
Disease ID:MONDO:0007450
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AD
Disease ID:MONDO:0007450
Submitter: Orphanet
Clinical Genomic Database (CGD)
Manifestation: Endocrine; Renal
Intervention: Endocrine; Renal
Rationale: Treatment/prevention of hypernatremia can be effective; Medications related to osteoporosis/osteopenia may be beneficial
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to AVP variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_000490.5. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 1 | 1 | 21 | 1 | 24 | |
| missense | 19 | 15 | 74 | 6 | 2 | 116 |
| nonsense | 3 | 1 | 2 | 6 | ||
| start loss | 1 | 1 | 2 | |||
| frameshift | 1 | 1 | ||||
| splice donor/acceptor (+/-2bp) | 1 | 2 | 1 | 4 | ||
| Total | 25 | 20 | 78 | 27 | 3 | 153 |
Highest pathogenic variant AF is 0.00005081156
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_000481.2 | 3 | MANE Select | |
| Ensembl | ENSP00000369647.3 | 3 | MANE Select |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Vasopressin-regulated water reabsorption - Homo sapiens (human)
- Phospholipase D signaling pathway - Homo sapiens (human)
- BMAL1-CLOCK,NPAS2 activates circadian gene expression
- Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways
- Signaling by GPCR
Biological Process
- maternal aggressive behavior
- positive regulation of systemic arterial blood pressure
- renal water homeostasis
- generation of precursor metabolites and energy
- water transport
Molecular Function
- protein kinase activity
- signaling receptor binding
- neuropeptide hormone activity
- neurohypophyseal hormone activity
- V1A vasopressin receptor binding
Cellular Component
- extracellular region
- extracellular space
- cytosol
- secretory granule
- dendrite
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000380293
- Coding exons
- 3
- Length
- 2169
- Individuals with no LoFs
- 125584
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 6
- Defined
- 125590
- p
- 0.0000239
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 1.05 | 40 | 63.7 | 0.628 | 0.00000351 | 1025 |
| Missense (PolyPhen) | 10 | 27.371 | 0.36534 | 352 | ||
| Synonymous | 0.468 | 27 | 30.3 | 0.892 | 0.00000204 | 330 |
| Loss of Function | 0.981 | 2 | 4.16 | 0.481 | 1.78e-7 | 58 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0 | 0.0 | absent |
| Latino/Admixed American | 0 | 0.0 | absent |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0 | 0.0 | absent |
| Finnish | 0 | 0.0 | absent |
| European (Non-Finnish) | 0.000044 | 0.000044 | rare |
| South Asian | 0.000033 | 0.000033 | rare |
| Other | 0 | 0.0 | absent |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Neurophysin 2 specifically binds vasopressin.;
- Disease
- DISEASE: Diabetes insipidus, neurohypophyseal (NDI) [MIM:125700]: A disease characterized by persistent thirst, polydipsia and polyuria. Affected individuals are apparently normal at birth, but characteristically develop symptoms of vasopressin deficiency during childhood. {ECO:0000269|PubMed:10369876, ECO:0000269|PubMed:10487710, ECO:0000269|PubMed:10677561, ECO:0000269|PubMed:11017955, ECO:0000269|PubMed:11150885, ECO:0000269|PubMed:11161827, ECO:0000269|PubMed:11443218, ECO:0000269|PubMed:11748489, ECO:0000269|PubMed:11980620, ECO:0000269|PubMed:12012274, ECO:0000269|PubMed:12107248, ECO:0000269|PubMed:12359138, ECO:0000269|PubMed:12519420, ECO:0000269|PubMed:12931042, ECO:0000269|PubMed:14510916, ECO:0000269|PubMed:14673472, ECO:0000269|PubMed:15538939, ECO:0000269|PubMed:1740104, ECO:0000269|PubMed:7714110, ECO:0000269|PubMed:8045958, ECO:0000269|PubMed:8103767, ECO:0000269|PubMed:8370682, ECO:0000269|PubMed:8514868, ECO:0000269|PubMed:8554046, ECO:0000269|PubMed:9360520, ECO:0000269|PubMed:9580132, ECO:0000269|PubMed:9814475}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- K
- Indispensability pred.
- E
- Indispensability score
- 0.585
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |